May 9, 2018 / 8:16 PM / 2 months ago

BRIEF-Miragen Therapeutics Reports Q1 Loss Per Share $0.18

May 9 (Reuters) - miRagen Therapeutics Inc:

* MIRAGEN THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 REVENUE $4.8 MILLION VERSUS $500,000

* Q1 REVENUE VIEW $1.2 MILLION -- THOMSON REUTERS I/B/E/S

* Q1 EARNINGS PER SHARE VIEW $-0.24 -- THOMSON REUTERS I/B/E/S

* CASH AND CASH EQUIVALENTS AT MARCH 31, 2018 WERE $78.1 MILLION, COMPARED TO $47.4 MILLION AT DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below